RZLT
RezoluteFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
RZLT vs peer average
15/100
RZLT vs. peer average (F vs. C)
Grade spread
A 3 · B 1 · C 2 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RNAC is the first available peer comparator.
Cartesian is another loose clinical-stage biotech comp with binary data sensitivity, but its modality and disease focus differ materially from Rezolute's HI program.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RZLT
Rezolute
RNAC
Cartesian Therapeutics
Grade
F
C
Momentum
32
56
Value
41
41
Sentiment
34
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs RNAC
RZLT / RNAC
Grade Position
Below peers
RZLT vs. peer average (F vs. C)
15/100
Momentum
32
RNACValue
41
RZLTSentiment
34
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RZLT
RNAC is the first peer returned for this comparison set.